{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:05:56Z","timestamp":1790089556849,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Supportive Plan for Top Innovative PhD Students at China Academy of Chinese Medical Sciences"},{"name":"the Fundamental Research Funds for the Central Public Welfare Research Institutes","award":["ZB2025009"],"award-info":[{"award-number":["ZB2025009"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82474682"],"award-info":[{"award-number":["82474682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["CI2023C063YLL"],"award-info":[{"award-number":["CI2023C063YLL"]}]},{"name":"the National Major Scientific and Technological Special Project for Significant New Drugs Development","award":["2017ZX09301059"],"award-info":[{"award-number":["2017ZX09301059"]}]},{"name":"the Open Research Fund of Chengdu University of Traditional Chinese Medicine Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bioinformatics and large-scale computational modelling have emerged as essential research fields in modern biomedical science, enabling drug discovery and therapeutic optimisation. A unique and potent technical framework for the modernisation and mechanistic clarification of traditional Chinese medicine (TCM) formulations is provided by the integration of multidimensional data using systems biology and artificial intelligence (AI) techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ankylosing spondylitis\u2013associated key hub genes were identified using multi-omics datasets, differential gene expression analysis, weighted gene co-expression network analysis, single-cell transcriptomic analysis, Mendelian randomization, and network module partitioning. In order to predict the optimal drug combinations and synergistic principal-auxiliary therapeutic roles, an interpretable, multi-layer graph convolutional network model was built using network topology features, molecular docking data, empirical clinical medication knowledge, and compound clustering similarity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eight AS-associated hub genes were found using AS as a representative disease model. A possible TCM formula, ASD-A, comprising\n                      <jats:italic>Myrrha<\/jats:italic>\n                      ,\n                      <jats:italic>Drynariae Rhizoma<\/jats:italic>\n                      ,\n                      <jats:italic>Lycii Fructus<\/jats:italic>\n                      ,\n                      <jats:italic>Epimedii Folium<\/jats:italic>\n                      ,\n                      <jats:italic>Achyranthis Bidentatae Radix<\/jats:italic>\n                      ,\n                      <jats:italic>Alpiniae Officinarum Rhizoma<\/jats:italic>\n                      ,\n                      <jats:italic>Forsythiae Fructus<\/jats:italic>\n                      ,\n                      <jats:italic>Astragali Radix,<\/jats:italic>\n                      was prioritised by the proposed model. While ablation studies highlighted the crucial role of multi-source information integration in compound formula screening and the creation of customised intervention methods, model performance evaluation showed strong predictive potential. The identified hub genes were found to be tightly linked to immunological responses and T-cell-mediated immune processes, according to functional enrichment analyses. Experiments conducted both in vivo and in vitro confirmed that ASD-A significantly reduced pro-inflammatory cytokines like IL-6 and TNF-\u03b1 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), modulated the proportions of CD80 and CD86 cell subsets, and regulated the expression of important genes like KRAS, SMAD2, and MAPK14 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Furthermore, in activated Jurkat cells, ASD-A significantly decreased IL17 fluorescence while increasing Foxp3 fluorescence (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), indicating a rebalancing of the IL17\/Foxp3 axis. The roles of major and auxiliary components in controlling hub gene activity were further clarified by formula decomposition analysis of ASD-A.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The suggested AI-driven formula design approach provides new insights into combinatorial therapy approaches for AS while also conforming to the TCM theory of\n                      <jats:italic>Jun-Chen-Zuo-Shi<\/jats:italic>\n                      principle. The significant potential of combining contemporary bioinformatics and AI techniques with traditional medicine is demonstrated by this study, which could facilitate efficient and mechanistically informed disease therapy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01385-1","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:33:38Z","timestamp":1774334018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["OptiSyn: an interpretable, multi-omics\u2013driven graph convolutional network framework for synergy-oriented drug combination design in disease treatment"],"prefix":"10.1186","volume":"21","author":[{"given":"Yinli","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoduan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuedan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"10","key":"1385_CR1","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.drudis.2021.05.008","volume":"26","author":"ZA Shyr","year":"2021","unstructured":"Shyr ZA, Cheng YS, Lo DC, et al. Drug combination therapy for emerging viral diseases. Drug Discov Today. 2021;26(10):2367\u201376. https:\/\/doi.org\/10.1016\/j.drudis.2021.05.008.","journal-title":"Drug Discov Today"},{"issue":"4","key":"1385_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12012","volume":"40","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Yang M, Wang S, et al. Emerging role of deep learning-based artificial intelligence in tumor pathology. Cancer Commun. 2020;40(4):154\u201366. https:\/\/doi.org\/10.1002\/cac2.12012.","journal-title":"Cancer Commun"},{"issue":"5","key":"1385_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/00273171.2022.2146638","volume":"58","author":"M Salditt","year":"2023","unstructured":"Salditt M, Humberg S, Nestler S. Gradient tree boosting for hierarchical data. Multivar Behav Res. 2023;58(5):911\u201337. https:\/\/doi.org\/10.1080\/00273171.2022.2146638.","journal-title":"Multivar Behav Res"},{"issue":"4","key":"1385_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.chmed.2024.08.004","volume":"16","author":"W Zhao","year":"2024","unstructured":"Zhao W, Wang B, Li S. Network pharmacology for traditional Chinese medicine in era of artificial intelligence. Chin Herb Med. 2024;16(4):558\u201360. https:\/\/doi.org\/10.1016\/j.chmed.2024.08.004.","journal-title":"Chin Herb Med"},{"issue":"1","key":"1385_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad518","volume":"25","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang D, Zhou W, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform. 2023;25(1):bbad518. https:\/\/doi.org\/10.1093\/bib\/bbad518.","journal-title":"Brief Bioinform"},{"issue":"3","key":"1385_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.19540\/j.cnki.cjcmm.20231010.601","volume":"49","author":"YY Wang","year":"2024","unstructured":"Wang YY, Wang Z. Essentials for high-quality development of fangjiomics. Zhongguo Zhong Yao Za Zhi. 2024;49(3):569\u201370. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20231010.601.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.csbj.2018.10.015","volume":"16","author":"PL Wei","year":"2018","unstructured":"Wei PL, Gu H, Liu J, et al. Development of Fangjiomics for systems elucidation of synergistic mechanism underlying combination therapy. Comput Struct Biotechnol J. 2018;16:565\u201372. https:\/\/doi.org\/10.1016\/j.csbj.2018.10.015.","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"1385_CR8","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00256-024-04812-2","volume":"54","author":"\u00c2 Massignan","year":"2025","unstructured":"Massignan \u00c2, Knabben MM, da Silva TB, et al. Review of the updated definitions and concepts of spinal lesions in axial spondyloarthritis. Skeletal Radiol. 2025;54(11):2227\u201341. https:\/\/doi.org\/10.1007\/s00256-024-04812-2.","journal-title":"Skeletal Radiol"},{"key":"1385_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104520","volume":"90","author":"A Perl","year":"2023","unstructured":"Perl A, Morel L. Expanding scope of TEMRA in autoimmunity. EBioMedicine. 2023;90:104520. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104520.","journal-title":"EBioMedicine"},{"issue":"9","key":"1385_CR10","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v16.i9.108629","volume":"16","author":"JS Lu","year":"2025","unstructured":"Lu JS, Yang M, Han ZG, et al. Therapeutic potential of traditional Chinese medicine for inflammatory bone diseases: elucidating molecular mechanisms and insights. World J Orthop. 2025;16(9):108629. https:\/\/doi.org\/10.5312\/wjo.v16.i9.108629.","journal-title":"World J Orthop"},{"issue":"8","key":"1385_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/14712598.2024.2389987","volume":"24","author":"G Lopalco","year":"2024","unstructured":"Lopalco G, Cito A, Venerito V, Iannone F, et al. The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations. Expert Opin Biol Ther. 2024;24(8):835\u201353. https:\/\/doi.org\/10.1080\/14712598.2024.2389987.","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"1385_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph17091230","volume":"17","author":"Y Shi","year":"2024","unstructured":"Shi Y, Liu J, Guan S, et al. Syn-COM: A multi-level predictive synergy framework for innovative drug combinations. Pharmaceuticals. 2024;17(9):1230. https:\/\/doi.org\/10.3390\/ph17091230.","journal-title":"Pharmaceuticals"},{"issue":"13","key":"1385_CR13","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.19540\/j.cnki.cjcmm.20240407.601","volume":"49","author":"B Li","year":"2024","unstructured":"Li B, Yu YN, Wang PQ, et al. Modular pharmacology: research progress and development of analysis platform. Zhongguo Zhong Yao Za Zhi. 2024;49(13):3414\u201320. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20240407.601.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1385_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118287","volume":"331","author":"S Zhang","year":"2024","unstructured":"Zhang S, Niu Q, Zong W, et al. Endotype-driven co-module mechanisms of Danhong injection in the co-treatment of cardiovascular and cerebrovascular diseases: a modular-based drug and disease integrated analysis. J Ethnopharmacol. 2024;331:118287. https:\/\/doi.org\/10.1016\/j.jep.2024.118287.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1385_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70329","volume":"29","author":"Y Shi","year":"2025","unstructured":"Shi Y, Guan S, Liu X, et al. Genetic commonalities between metabolic syndrome and rheumatic diseases through disease interactome modules. J Cell Mol Med. 2025;29(1):e70329. https:\/\/doi.org\/10.1111\/jcmm.70329.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1385_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41380-025-03205-8","volume":"31","author":"P Segura","year":"2026","unstructured":"Segura P, Pagani M, Bishop SL, et al. Connectome-based symptom mapping and in silico related gene expression in children with autism and\/or attention-deficit\/hyperactivity disorder. Mol Psychiatry. 2026;31(1):282\u201395. https:\/\/doi.org\/10.1038\/s41380-025-03205-8.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1385_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09186-x","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng F, Kov\u00e1cs IA, Barab\u00e1si AL. Network-based prediction of drug combinations. Nat Commun. 2019;10(1):1197. https:\/\/doi.org\/10.1038\/s41467-019-09186-x.","journal-title":"Nat Commun"},{"key":"1385_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157246","volume":"148","author":"L Fu","year":"2025","unstructured":"Fu L, Xie J, Wang Z, et al. Comparison of the efficacy and action mechanism of Chinese patent medicines for liver fibrosis and cirrhosis. Phytomedicine. 2025;148:157246. https:\/\/doi.org\/10.1016\/j.phymed.2025.157246.","journal-title":"Phytomedicine"},{"issue":"1","key":"1385_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-25538-8","volume":"15","author":"AK Kushwaha","year":"2025","unstructured":"Kushwaha AK, Kumar H, Arora H, et al. A deep embedded clustering method for location-specific driving safety profiling using trajectory data. Sci Rep. 2025;15(1):41635. https:\/\/doi.org\/10.1038\/s41598-025-25538-8.","journal-title":"Sci Rep"},{"key":"1385_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114751","volume":"283","author":"A Azfaralariff","year":"2022","unstructured":"Azfaralariff A, Farahfaiqah F, Shahid M, et al. Marantodes pumilum: Systematic computational approach to identify their therapeutic potential and effectiveness. J Ethnopharmacol. 2022;283:114751. https:\/\/doi.org\/10.1016\/j.jep.2021.114751.","journal-title":"J Ethnopharmacol"},{"issue":"Suppl 4","key":"1385_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-S4-S11","volume":"12","author":"AR Santos","year":"2011","unstructured":"Santos AR, Santos MA, Baumbach J, et al. A singular value decomposition approach for improved taxonomic classification of biological sequences. BMC Genomics. 2011;12(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1471-2164-12-S4-S11.","journal-title":"BMC Genomics"},{"issue":"2","key":"1385_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5483\/BMBRep.2024-0155","volume":"58","author":"M Whangbo","year":"2025","unstructured":"Whangbo M, Ko E, Kim D, et al. Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation. BMB Rep. 2025;58(2):75\u201381. https:\/\/doi.org\/10.5483\/BMBRep.2024-0155.","journal-title":"BMB Rep"},{"issue":"4","key":"1385_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004886","volume":"10","author":"Y Teng","year":"2024","unstructured":"Teng Y, Yin H, Feng R, et al. Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-\u03b3R\/STAT1 pathway in the treatment of rheumatoid arthritis. RMD Open. 2024;10(4):e004886. https:\/\/doi.org\/10.1136\/rmdopen-2024-004886.","journal-title":"RMD Open"},{"key":"1385_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3706421","volume":"2023","author":"B Liu","year":"2023","unstructured":"Liu B, Wu Y, Liang T, et al. Betulinic Acid attenuates Osteoarthritis via limiting NLRP3 inflammasome activation to decrease Interleukin-1\u03b2 maturation and secretion. Mediators Inflamm. 2023;2023:3706421. https:\/\/doi.org\/10.1155\/2023\/3706421.","journal-title":"Mediators Inflamm"},{"key":"1385_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935534","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Zhang X, Ma Y, et al. FOXO3a alleviates the inflammation and oxidative stress via regulating TGF-\u03b2 and HO-1 in Ankylosing Spondylitis. Front Immunol. 2022;13:935534. https:\/\/doi.org\/10.3389\/fimmu.2022.935534.","journal-title":"Front Immunol"},{"key":"1385_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101981","volume":"89","author":"W Li","year":"2023","unstructured":"Li W, Yu L, Li W, et al. Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: underlying mechanisms based on cell and molecular targets. Ageing Res Rev. 2023;89:101981. https:\/\/doi.org\/10.1016\/j.arr.2023.101981.","journal-title":"Ageing Res Rev"},{"key":"1385_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2403935","volume":"2018","author":"IT Chyuan","year":"2018","unstructured":"Chyuan IT, Chen JY. Role of Interleukin- (IL-) 17 in the pathogenesis and targeted therapies in Spondyloarthropathies. Mediators Inflamm. 2018;2018:2403935. https:\/\/doi.org\/10.1155\/2018\/2403935.","journal-title":"Mediators Inflamm"},{"issue":"8","key":"1385_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12081873","volume":"12","author":"HC Yu","year":"2024","unstructured":"Yu HC, Wang ST, Lu MC. Dysregulated non-coding RNA expression in T cells from patients with Ankylosing Spondylitis contributes to its immunopathogenesis. Biomedicines. 2024;12(8):1873. https:\/\/doi.org\/10.3390\/biomedicines12081873.","journal-title":"Biomedicines"},{"issue":"44","key":"1385_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503979","volume":"12","author":"J Zhu","year":"2025","unstructured":"Zhu J, Huang L, Bi S, et al. Vitiligo signature-based drug screening identifies Fulvestrant as a novel immunotherapy combination strategy. Adv Sci. 2025;12(44):e03979. https:\/\/doi.org\/10.1002\/advs.202503979.","journal-title":"Adv Sci"},{"key":"1385_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1562261","volume":"16","author":"Q Liu","year":"2025","unstructured":"Liu Q, Chen H, Tang D, et al. Biological and prognostic insights into the prostaglandin D2 signaling axis in lung adenocarcinoma. Front Pharmacol. 2025;16:1562261. https:\/\/doi.org\/10.3389\/fphar.2025.1562261.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1385_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/19373341251360742","volume":"31","author":"I Singh","year":"2025","unstructured":"Singh I, Morrisson M, Shenk S, et al. T cells enhance tissue complexity and function to study fibrosis in 3D skin-like tissue models. Tissue Eng Part C Methods. 2025;31(7):248\u201360. https:\/\/doi.org\/10.1177\/19373341251360742.","journal-title":"Tissue Eng Part C Methods"},{"issue":"6","key":"1385_CR32","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12026-024-09522-4","volume":"72","author":"Q Li","year":"2024","unstructured":"Li Q, Wang G, Yuan Z, et al. Circulating CD8\u2009+\u2009LGALS9\u2009+\u2009T cell population exhibiting low cytotoxic characteristics are decreased in patients with Systemic Lupus Erythematosus. Immunol Res. 2024;72(6):1238\u201346. https:\/\/doi.org\/10.1007\/s12026-024-09522-4.","journal-title":"Immunol Res"},{"issue":"1","key":"1385_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04443-2","volume":"26","author":"Y Wang","year":"2025","unstructured":"Wang Y, Tang Q, Sun Q. INHBA knockdown inhibits renal fibrosis in mice following ischemia-reperfusion injury by suppressing activation of the TGF-\u03b2\/Smad signaling pathway. BMC Nephrol. 2025;26(1):526. https:\/\/doi.org\/10.1186\/s12882-025-04443-2.","journal-title":"BMC Nephrol"},{"key":"1385_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394438","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu W, Lai J, et al. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers. Front Immunol. 2024;15:1394438. https:\/\/doi.org\/10.3389\/fimmu.2024.1394438.","journal-title":"Front Immunol"},{"issue":"18","key":"1385_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188921","volume":"26","author":"A Donniacuo","year":"2025","unstructured":"Donniacuo A, Mauro A, Cardamone C, et al. Comprehensive profiling of cytokines and growth factors: pathogenic roles and clinical applications in autoimmune diseases. Int J Mol Sci. 2025;26(18):8921. https:\/\/doi.org\/10.3390\/ijms26188921.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1385_CR36","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1007\/s11030-024-11019-z","volume":"29","author":"C Ding","year":"2025","unstructured":"Ding C, Liu Q, You X, et al. Investigating the molecular mechanism of Epimedium herb in treating rheumatoid arthritis through network pharmacology, molecular docking, and experimental validation. Mol Divers. 2025;29(5):4061\u201381. https:\/\/doi.org\/10.1007\/s11030-024-11019-z.","journal-title":"Mol Divers"},{"issue":"6","key":"1385_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s11596-024-2925-8","volume":"44","author":"N Li","year":"2024","unstructured":"Li N, Yi YK, Zhao J, et al. Kaempferol improved rheumatoid arthritis by regulating the immune imbalance of Treg\/Th17. Curr Med Sci. 2024;44(6):1259\u201369. https:\/\/doi.org\/10.1007\/s11596-024-2925-8.","journal-title":"Curr Med Sci"},{"issue":"1","key":"1385_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10397-3","volume":"52","author":"HM Jaafar","year":"2025","unstructured":"Jaafar HM, Ameen DMH, Mohammad TAM, et al. The effects of nanocurcumin on immune-related factors in the ankylosing spondylitis patients: a double-blind, randomized, placebo-controlled clinical trial. Mol Biol Rep. 2025;52(1):324. https:\/\/doi.org\/10.1007\/s11033-025-10397-3.","journal-title":"Mol Biol Rep"},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.intimp.2019.05.030","volume":"73","author":"C Liu","year":"2019","unstructured":"Liu C, Chen Y, Lu C, et al. Betulinic acid suppresses Th17 response and ameliorates psoriasis-like murine skin inflammation. Int Immunopharmacol. 2019;73:343\u201352. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.030.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"1385_CR40","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s41401-025-01536-4","volume":"46","author":"SL Yu","year":"2025","unstructured":"Yu SL, Wu ML, Li PH, et al. Calycosin synergizes with methotrexate in the treatment of Sj\u00f6gren\u2019s disease by targeting BATF in T follicular helper cells. Acta Pharmacol Sin. 2025;46(7):1990\u20132005. https:\/\/doi.org\/10.1038\/s41401-025-01536-4.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01385-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:33:40Z","timestamp":1774334020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01385-1","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}